Zalifrelimab
Zalifrelimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Zalifrelimab is under investigation in clinical trial NCT03894215 (Phase 2 Study of Anti-pd-1 Independently or in Combination With Anti-ctla-4 in Second-line Cervical Cancer).
| Trade Name | Zalifrelimab |
| Generic | Zalifrelimab |
| Zalifrelimab Other Names | Zalifrelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Zalifrelimab
